CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)
Hong Kong
· Delayed Price · Currency is HKD 0.780
+0.010 (1.30%)
Mar 10, 2026, 1:50 PM HKT
HKG:0775 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,401 | 3,941 | 5,959 | 7,593 | 7,112 | 8,458 | Upgrade
|
| Market Cap Growth | 50.98% | -33.87% | -21.52% | 6.76% | -15.91% | 1.15% | Upgrade
|
| Enterprise Value | 13,099 | 9,325 | 11,391 | 12,901 | 12,597 | 13,689 | Upgrade
|
| Last Close Price | 0.77 | 0.41 | 0.62 | 0.78 | 0.72 | 0.85 | Upgrade
|
| PE Ratio | - | - | 345.44 | 57.54 | 43.69 | 67.54 | Upgrade
|
| Forward PE | - | 13.75 | 13.75 | 13.75 | 13.75 | 13.75 | Upgrade
|
| PS Ratio | 1.35 | 0.71 | 1.12 | 1.44 | 1.32 | 1.71 | Upgrade
|
| PB Ratio | 2.03 | 1.12 | 1.42 | 1.83 | 1.58 | 1.79 | Upgrade
|
| P/TBV Ratio | 12.88 | 8.01 | 5.76 | 7.79 | 5.66 | 6.03 | Upgrade
|
| P/FCF Ratio | 1335.11 | 25.10 | 26.31 | 51.43 | 34.30 | 43.26 | Upgrade
|
| P/OCF Ratio | 36.62 | 11.15 | 11.59 | 20.88 | 16.79 | 15.93 | Upgrade
|
| EV/Sales Ratio | 2.38 | 1.69 | 2.14 | 2.45 | 2.33 | 2.77 | Upgrade
|
| EV/EBITDA Ratio | 97.94 | 38.23 | 29.92 | 32.76 | 31.47 | 60.48 | Upgrade
|
| EV/EBIT Ratio | - | 120.37 | 50.89 | 53.77 | 53.24 | 161.52 | Upgrade
|
| EV/FCF Ratio | 2363.24 | 59.39 | 50.29 | 87.38 | 60.75 | 70.02 | Upgrade
|
| Debt / Equity Ratio | 1.78 | 1.74 | 1.42 | 1.43 | 1.38 | 1.31 | Upgrade
|
| Debt / EBITDA Ratio | 48.75 | 18.91 | 12.96 | 12.63 | 12.85 | 20.29 | Upgrade
|
| Debt / FCF Ratio | 1172.06 | 38.85 | 26.19 | 40.27 | 29.96 | 31.66 | Upgrade
|
| Net Debt / Equity Ratio | 1.56 | 1.57 | 1.25 | 1.26 | 1.18 | 1.11 | Upgrade
|
| Net Debt / EBITDA Ratio | 104.41 | 22.66 | 13.80 | 13.31 | 13.27 | 23.06 | Upgrade
|
| Net Debt / FCF Ratio | 1028.12 | 35.21 | 23.20 | 35.51 | 25.61 | 26.69 | Upgrade
|
| Asset Turnover | 0.50 | 0.50 | 0.47 | 0.46 | 0.46 | 0.44 | Upgrade
|
| Inventory Turnover | 3.10 | 3.24 | 2.96 | 2.88 | 2.88 | 2.77 | Upgrade
|
| Quick Ratio | 0.88 | 0.72 | 0.78 | 0.42 | 0.87 | 1.98 | Upgrade
|
| Current Ratio | 1.49 | 1.28 | 1.43 | 0.77 | 1.53 | 3.60 | Upgrade
|
| Return on Equity (ROE) | -7.26% | -3.29% | 0.41% | 3.05% | 3.53% | 2.82% | Upgrade
|
| Return on Assets (ROA) | -0.61% | 0.44% | 1.24% | 1.30% | 1.25% | 0.47% | Upgrade
|
| Return on Invested Capital (ROIC) | -1.16% | 0.84% | 0.60% | 1.61% | 1.64% | 0.89% | Upgrade
|
| Return on Capital Employed (ROCE) | -1.20% | 0.90% | 2.40% | 3.30% | 2.50% | 0.80% | Upgrade
|
| Earnings Yield | -3.76% | -3.21% | 0.29% | 1.74% | 2.29% | 1.48% | Upgrade
|
| FCF Yield | 0.07% | 3.98% | 3.80% | 1.94% | 2.92% | 2.31% | Upgrade
|
| Dividend Yield | - | - | - | 1.02% | 1.39% | 1.18% | Upgrade
|
| Payout Ratio | - | - | 445.73% | 72.83% | 59.04% | 76.74% | Upgrade
|
| Total Shareholder Return | - | - | - | 1.02% | 1.39% | 1.18% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.